Watch Dr. Kaneko, Chief of Cardiac Surgery at Washington University, and Prof. Borger, Director of Cardiac Surgery and Medical Director, Leipzig Heart Centre, discuss what a low rate of reoperation means for patients. https://t.co/u7P7GsD2SL
#CardiacSurgery#RESILIAtissue
For #heartvalve patients who need a #surgical intervention, navigating the options can be overwhelming. Help your patients learn about the latest advancements in tissue technology with #RESILIA tissue heart valves. https://t.co/BJMkLEQ7aX
The #MITRIS#RESILIA mitral valve tackles the unique challenges of replacement in the mitral position. Watch Dr. Acker discuss how it addresses the needs of patients with complex anatomies including calcification.
Watch full interview & explore newsletter: https://t.co/xiRgnW9kBT
Register now for the upcoming Aortic Regurgitation webinar. Join expert panelists as they discuss the need to improve aortic regurgitation severity assessment through multimodality imaging.
📅September 16, 2025🕕3:00PM PT / 6:00PM ET
Register now! ➡️ https://t.co/eIYnznnmQc
Join us at #NYValves2025 for an insightful discussion on #tricuspid valve surgery practice patterns, surgical outcome trends with the STS database, and an overview of transcatheter treatment options. Don't miss our lunch symposium!
#AATS2025 will feature the latest real-world data on the first pre-assembled #aortic tissue valved conduit.
🗓️ Learn more at our evening symposia and add it to your calendar: https://t.co/05EF1HoNp4
⚠️ Important safety info: https://t.co/g5aj1TuHOm
Headed to #AATS2025? Visit booth #605 for the latest real-world data on the #RESILIA tissue #surgical valve portfolio—and don’t miss our immersive “silent disco” presentations.
Learn more: https://t.co/qd2X8Dtg0l
⚠️ Important safety info: https://t.co/ixL8V7wtml
Join us today to discover the latest real-world data on the pre-assembled KONECT #RESILIA#aortic valved conduit at #STS2025!
🗓️ Don’t miss out—add the symposium to your calendar now: https://t.co/vyrABc3XVb
⚠️Important safety info: https://t.co/d8fMMk9viM
Dive into #mitral valve lifetime management at #STS2025.
🗓️ Don’t miss out—add the symposium to your calendar now: https://t.co/vtUWUNMhQ9
⚠️Important safety info: https://t.co/fEAFruPUzA
Join #STS2025 as we unveil the latest real-world data for the pre-assembled KONECT #RESILIA#aortic valved conduit.
🗓️ Don’t miss out—add the symposium to your calendar now: https://t.co/u2vPjUn5rJ
⚠️Important safety info: https://t.co/V8lL3eJ0nd
#STS2025 is the debut of the latest real-world data for the 1st pre-assembled #aortic valved conduit.🗓️Learn more about the symposia and add it to your calendar: https://t.co/JS7xsWuUiB
⚠️Important safety info: https://t.co/vsjMcn9tUu
Headed to #STS2025? Stop by our booth to get the latest on the #RESILIA tissue #surgical valve portfolio featuring real-world data and more. Learn more https://t.co/zMHlt4hg3t. ⚠️Important safety info: https://t.co/3qMOxgnmXf
How are lifetime management strategies incorporated during #heartvalve selection for #aorticstenosis patients? See what #surgeons had to say and learn how the RESILIA #tissuevalve portfolio may help https://t.co/zfXtLzy27e
⚠️ Important Safety Info: https://t.co/PcJP6hCYS5
Review the #COMMENCEtrial 7-year bicuspid aortic valve sub-analysis that demonstrated encouraging results for patients ≤ 65 years old with #RESILIAtissue valves.
>>>See the findings https://t.co/8a5VWhZGgW
⚠ Important Safety Info: https://t.co/TgSkEguk0L
A lot goes into selecting a valve for #mitralvalvesurgery. How do your peers weigh the options?⚖️
➡️Learn how the MITRIS RESILIA mitral valve meets these needs https://t.co/sSmCZAvli5
⚠️Important safety info: https://t.co/uBWNFaVTJC
🎙️ Edwards Lifesciences GM and SVP, Wayne Markowitz, sat down with DeviceTalks to discuss the evolving landscape of the structural heart space, and Edwards’ commitment to innovation by partnering with cardiac surgeons to address unmet patient needs.
➡️https://t.co/Ae7Yc3N6Bu
Designed with future considerations in mind, the #RESILIA tissue #surgical valve portfolio is helping patients rethink what’s possible. Learn how RESILIA tissue valves can help patients meet their future more confidently.
https://t.co/jtmzvvkbZF
The #RESILIA tissue #surgical valve portfolio is the result of innovation built on a proven platform—the Carpentier-Edwards PERIMOUNT valve platform, to be exact. Backed by 30 years of durability data, we continue to push performance forward. Learn more https://t.co/dPoLKD3xqk
The #RESILIA tissue surgical valve portfolio is pushing performance forward. Learn about the strong, growing base of clinical evidence, including the latest results of the ongoing #COMMENCE trial. Learn more https://t.co/CbyaCQJExM
Did you miss the last Etiology of #Mitral Valve Disease course? Don’t worry, another is on the way. Gain a solid foundation on the optimal management of mitral valve disease in a live case observation. Contact your local rep for more information.